Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.52
Price to sales ratio
2.95

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
907
RDY
Dr. Reddy's Laboratories Ltd
12.18 USD+0.25%-0.49%+3.31%-14.23%10.17 B USD
1058
ALKS
Alkermes plc - Ordinary Shares
47.41 USD-3.05%-1.33%-0.92%+62.86%7.95 B USD
1274
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
17.54 USD-2.61%-1.79%-3.73%+66.26%5.60 B USD
1492
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
34.87 USD-1.22%-4.54%-13.22%+3.78%4.12 B USD

Frequently asked questions about Lantheus Holdings, Inc

What is the Lantheus Holdings, Inc stock price today?

The current price of Lantheus Holdings, Inc (LNTH) is 100.77. Over the past 24 hours, the stock has changed by +0.30%. Follow the LNTH chart for real-time price dynamics.

What is the stock ticker of Lantheus Holdings, Inc?

Lantheus Holdings, Inc trades under the ticker LNTH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Lantheus Holdings, Inc stock going up?

LNTH has changed by +0.67% over the last week, +0.20% over the last month, and +79.75% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Lantheus Holdings, Inc?

Lantheus Holdings, Inc currently has a market capitalization of 6.58 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Lantheus Holdings, Inc earnings last quarter?

Last quarter, Lantheus Holdings, Inc reported earnings of 1.15 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Lantheus Holdings, Inc revenue for the last quarter?

Lantheus Holdings, Inc reported quarterly revenue of 388.18 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Lantheus Holdings, Inc net income for the last quarter?

Lantheus Holdings, Inc reported net income of 75.03 M for the last quarter. The previous quarter showed 118.42 M, which means net income changed by -36.64%.

How many employees does Lantheus Holdings, Inc have?

As of the latest available data, Lantheus Holdings, Inc has 1 193 employees. Workforce size can provide additional context about the company's scale and operations.

What is Lantheus Holdings, Inc EBITDA?

Lantheus Holdings, Inc EBITDA is 222.54 M, and its EBITDA margin is 57.33%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Lantheus Holdings, Inc stock?

You can buy Lantheus Holdings, Inc (LNTH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Lantheus Holdings, Inc stock?

Investing in Lantheus Holdings, Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LNTH chart and related analysis on metatrader.com as part of your research.

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

News